About Freenome

Freenome brings accurate and non-invasive disease screening to proactively treat cancer

Target Market

Personal Healthcare

Product and Services

Freenome brings accurate and non-invasive disease screening to proactively treat cancer

Founders

Leadership Team

Investors

Awards

Name	Description	Date

Fundings

Stage	Amount	Date
Series E	$254M	2024

Valuations

Amount	Date